CD146 is a potential marker for the diagnosis of malignancy in cervical and endometrial cancer
Authors:
Open Access
- 22 January 2013
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 5 (4) , 1189-1194
Abstract
Cluster of differentiation 146 (CD146) is an endothelial cell adhesion molecule which is overexpressed in various types of malignant cancer, including ovarian cancer. However, whether CD146 is overexpressed in another two types of gynecological cancer, cervical cancer and endometrial cancer, remains unclear. In the present study, we showed that CD146 expression levels were higher in cells from cervical cancer and endometrial cancer compared with their corresponding normal tissues, using anti-CD146 mouse antibody AA4 (mAb AA4) and that mAb AA4 exhibited a high performance for specificity, sensitivity and positive predictive value in the detection of these two types of cancer. CD146 expression was positively and significantly correlated with the pathological subtype of cervical cancer and with the histological grade and depth of myometrial invasion in endometrial cancer. In addition, we confirmed that CD146 is present in the majority of blood vessels in cervical and endometrial cancer, suggesting that CD146 may be actively implicated in the metastasis of cervical and endometrial cancer via the vascular system. Thus, this study provides insights for further development of CD146 mAb in the detection of gynecological malignant cancer types and implies that a combined treatment strategy of anti-CD146 immunotherapy with other traditional chemo- or radiotherapy treatments may be a promising approach against cervical and endometrial cancer.Keywords
This publication has 30 references indexed in Scilit:
- CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric CancerInternational Journal of Molecular Sciences, 2012
- CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancerProceedings of the National Academy of Sciences, 2011
- Protein Biomarkers of Ovarian Cancer: The Forest and The TreesFuture Oncology, 2011
- Enforced Expression of METCAM/MUC18 Increases Tumorigenesis of Human Prostate Cancer LNCaP Cells in Nude MiceJournal of Urology, 2011
- Endothelial CD146 is required for in vitro tumor-induced angiogenesis: The role of a disulfide bond in signaling and dimerizationThe International Journal of Biochemistry & Cell Biology, 2009
- Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- Generation and Characterization of a Panel of Monoclonal Antibodies Against Distinct Epitopes of Human CD146Hybridoma, 2008
- HEMCAM, an adhesion molecule expressed by c-kit+ hemopoietic progenitors.Journal of Cell Biology, 1996
- Identification of the S-Endo 1 Endothelial-Associated AntigenBiochemical and Biophysical Research Communications, 1996
- The progression associated antigen MUC18Melanoma Research, 1993